224 related articles for article (PubMed ID: 32009220)
1. Economic burden and cost-utility analysis of three renal replacement therapies in ESRD patients from Yunnan Province, China.
Wu H; Li Q; Cai Y; Zhang J; Cui W; Zhou Z
Int Urol Nephrol; 2020 Mar; 52(3):573-579. PubMed ID: 32009220
[TBL] [Abstract][Full Text] [Related]
2. Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China.
Zhang H; Zhang C; Zhu S; Ye H; Zhang D
BMC Health Serv Res; 2020 Feb; 20(1):122. PubMed ID: 32059726
[TBL] [Abstract][Full Text] [Related]
3. Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis.
Wong CKH; Chen J; Fung SKS; Mok MMY; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
Nephrol Dial Transplant; 2019 Sep; 34(9):1565-1576. PubMed ID: 30668781
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
Yang F; Lau T; Luo N
Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
[TBL] [Abstract][Full Text] [Related]
5. Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy.
Wong CKH; Chen J; Fung SKS; Mok M; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
BMC Nephrol; 2020 Feb; 21(1):42. PubMed ID: 32019528
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand.
Teerawattananon Y; Mugford M; Tangcharoensathien V
Value Health; 2007; 10(1):61-72. PubMed ID: 17261117
[TBL] [Abstract][Full Text] [Related]
7. Financial implications of dialysis modalities in the developing world: A Chinese perspective.
Liu J; Hutton DW; Gu Y; Hu Y; Li Y; Ma L; Zeng X; Fu P
Perit Dial Int; 2020 Mar; 40(2):193-201. PubMed ID: 32063196
[TBL] [Abstract][Full Text] [Related]
8. Peritoneal dialysis vs. hemodialysis among patients with end-stage renal disease in Iran: which is more cost-effective?
Yousefi M; Rezaei S; Hajebrahimi S; Falsafi N; Keshvari-Shad F
BMC Nephrol; 2024 Mar; 25(1):85. PubMed ID: 38448887
[TBL] [Abstract][Full Text] [Related]
9. Filtering for the best policy: An economic evaluation of policy options for kidney replacement coverage in the Philippines.
Bayani DBS; Almirol BJQ; Uy GDC; Taneo MJS; Danguilan RS; Arakama MI; Lamban AB; de Leon D; Pamugas GEP; Luz AC; Teerawatananon Y
Nephrology (Carlton); 2021 Feb; 26(2):170-177. PubMed ID: 33207027
[TBL] [Abstract][Full Text] [Related]
10. Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter?
Yang F; Devlin N; Luo N
Value Health; 2019 Jan; 22(1):45-49. PubMed ID: 30661633
[TBL] [Abstract][Full Text] [Related]
11. Comparison of hemodialysis and peritoneal dialysis--a cost-utility analysis.
Sennfält K; Magnusson M; Carlsson P
Perit Dial Int; 2002; 22(1):39-47. PubMed ID: 11929142
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes in lupus patients receiving different renal replacement therapy.
Tsai WT; Chang HC; Wang CT; Chiang BL; Lin YT
J Microbiol Immunol Infect; 2019 Aug; 52(4):648-653. PubMed ID: 30642809
[TBL] [Abstract][Full Text] [Related]
13. Cost/Utility study of peritoneal dialysis and hemodialysis in Chile.
Pacheco A; Saffie A; Torres R; Tortella C; Llanos C; Vargas D; Sciaraffia V
Perit Dial Int; 2007; 27(3):359-63. PubMed ID: 17468491
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of three dialysis methods in patients with end-stage renal disease in China.
Hong Z; Zhuang Y; Lu J; Ye J; Sun H; Gao L; Xiong Y
Int Urol Nephrol; 2023 May; 55(5):1247-1254. PubMed ID: 36376531
[TBL] [Abstract][Full Text] [Related]
15. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
[TBL] [Abstract][Full Text] [Related]
16. Cost analysis of renal replacement therapy by transplant in a system of bundled payment of dialysis.
Rocha MJ; Ferreira S; Martins LS; Almeida M; Dias L; Pedroso S; Henriques AC; Almeida R; Cabrita A
Clin Transplant; 2012; 26(4):529-31. PubMed ID: 22211715
[TBL] [Abstract][Full Text] [Related]
17. The other side of the coin in renal replacement therapies: the burden on caregivers.
Bardak S; Demir S; Aslan E; Turgutalp K; Celikcan HD; Dolarslan ME; Kılıcarslan C; Karasu F; Gunes AJ; Kurt C; Kıykım A
Int Urol Nephrol; 2019 Feb; 51(2):343-349. PubMed ID: 30515731
[TBL] [Abstract][Full Text] [Related]
18. Cost analysis of hemodialysis and peritoneal dialysis access in incident dialysis patients.
Coentrão LA; Araújo CS; Ribeiro CA; Dias CC; Pestana MJ
Perit Dial Int; 2013; 33(6):662-70. PubMed ID: 23455977
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Patient Survival Between Hemodialysis and Peritoneal Dialysis Among Patients Eligible for Both Modalities.
Wong B; Ravani P; Oliver MJ; Holroyd-Leduc J; Venturato L; Garg AX; Quinn RR
Am J Kidney Dis; 2018 Mar; 71(3):344-351. PubMed ID: 29174322
[TBL] [Abstract][Full Text] [Related]
20. Economic analysis of the treatment of end-stage renal disease treatment: living-donor kidney transplantation versus hemodialysis.
Sánchez-Escuredo A; Alsina A; Diekmann F; Revuelta I; Esforzado N; Ricart MJ; Cofán F; Torregrosa JV; Campistol JM; Oppenheimer F; Fernandez E
Transplant Proc; 2015; 47(1):30-3. PubMed ID: 25645763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
